Haley D. Neff‐LaFord

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index

Robert P. Lyon, Tim D. Bovee, Svetlana O. Doronina et al. · Nature Biotechnology · 2015 · 523 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +14

Aryl Hydrocarbon Receptor Activation during Influenza Virus Infection Unveils a Novel Pathway of IFN-γ Production by Phagocytic Cells

Haley D. Neff‐LaFord, Sabine Teske, Timothy Bushnell et al. · The Journal of Immunology · 2007 · 71 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice

Haley D. Neff‐LaFord, Beth A. Vorderstrasse, B. Paige Lawrence · Cellular Immunology · 2003 · 50 citations

Life Sciences, Immunology, Infectious Diseases +15

Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophages

Florian Bea, Francesca N. Hudson, Haley D. Neff‐LaFord et al. · Atherosclerosis · 2008 · 22 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

The Vedotin Antibody–Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles

Haley D. Neff‐LaFord, Sarah A. Carratt, Christopher M. Carosino et al. · Molecular Cancer Therapeutics · 2024 · 20 citations · Full text

Pharmacy, Pharmacology, Toxicology +14